Hiroyuki Tsunoda
Chugai Pharma (United States)(US)
Publications by Year
Research Areas
Cancer Immunotherapy and Biomarkers, Monoclonal and Polyclonal Antibodies Research, Immune cells in cancer, Ferroptosis and cancer prognosis, Immune Cell Function and Interaction
Most-Cited Works
- → A bispecific antibody to factors IXa and X restores factor VIII hemostatic activity in a hemophilia A model(2012)491 cited
- → Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases(2021)330 cited
- → Identification of Soluble NH2-Terminal Fragment of Glypican-3 as a Serological Marker for Early-Stage Hepatocellular Carcinoma(2004)295 cited
- → Reduced elimination of IgG antibodies by engineering the variable region(2010)260 cited
- → Factor VIIIa-mimetic cofactor activity of a bispecific antibody to factors IX/IXa and X/Xa, emicizumab, depends on its ability to bridge the antigens(2017)196 cited
- → Anti–Glypican 3 Antibody as a Potential Antitumor Agent for Human Liver Cancer(2008)176 cited